PCRX FY 2025 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$971M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$726M+3.6% YoY

Gross Profit

$519M71.5% margin

Operating Income

$28M3.9% margin

Net Income

$7M1.0% margin

EPS (Diluted)

$0.16

Cash Flow

Operating Cash Flow

$152M

Free Cash Flow

$137M

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$572M

Stockholders' Equity

$693M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$726M	$701M	+3.6%
Gross Profit	$519M	$531M	-2.1%
Operating Income	$28M	-$73M	+138.3%
Net Income	$7M	-$100M	+107.1%